-
Subtype‐specific enhancer RNAs define transcriptional regulators and prognosis in breast cancers
-
Identification and Validation of a Novel 2-LncRNAs Signature Associated with m6A Regulation in Colorectal Cancer
-
Extracellular Vesicles in Pancreatic Cancer Function and Potential Clinical Applications
-
Clinical impact of trace elements as potential biomarkers for diagnosis and prediction of response to systemic treatment in gastrointestinal cancers
-
Clinical Utility of Comprehensive Genomic Profiling for Advanced Non‐Small Cell Lung Cancer: A Single‐Center Retrospective Study
-
The clinical impact of androgens in endometrial cancer: cancer promoter or suppressor?
-
Safety and Clinical Outcomes of Kanglaite Injection in Combination with Toripalimab and Chemotherapy for Advanced Non-Small Cell Lung Cancer: A Real-World Retrospective Analysis
-
Antidiabetic agents as potential cytotoxic candidates for cancer therapy
-
Salidroside-Based Nanomedicines for Triple-Negative Breast Cancer: From Molecular Mechanisms to Clinical Translation
-
Prospective Multicenter Observational Study of Anlotinib in Advanced Non‐Small Cell Lung Cancer: Real‐World Evidence From China
-
Reproductive concerns of children and adolescents with cancer: challenges and potential solutions
-
Watch and Wait Strategy for Locally Advanced Rectal Cancer: Update From Results of Recent Clinical Trials
-
Clinical Manifestations and Outcomes of Lung Cancer Patients With Appendiceal Metastasis
-
Reviewer Acknowledgements for Cancer and Clinical Oncology, Vol. 8, No. 1
-
Clinical Factors Associated With Non‐Completion of Durvalumab Maintenance Therapy After Chemoradiotherapy in Patients With Locally Advanced Non‐Small Cell Lung Cancer: A Single‐Center Retrospective Study
-
Traditional Chinese Medicine for lung cancer: Mechanisms, clinical evidence, and future perspectives
-
Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST Study
-
Radiotherapy and Cardiovascular Disease Survival Risk in Non‐Small Cell Lung Cancer: A Population‐Based Study From the Surveillance, Epidemiology, and End Results Database
-
Brain metastases in non-small cell lung cancer: Prevalence, high-risk factors, and overall survival prognosis
-
Lobe‐Specific Versus Systematic Lymph Node Dissection in Clinical Stage I Non‐Small Cell Lung Cancer: A Propensity Score‐Matched Analysis Based on the 8th Edition of the TNM Stage Classification
-
Correction to “Radiotherapy and Cardiovascular Disease Survival Risk in Non‐Small Cell Lung Cancer: A Population‐Based Study From the Surveillance, Epidemiology, and End Results Database”
-
Novel Insights into the Oncogenic Role and Clinical Significance of ORC6L in Breast Cancer
-
Abemaciclib in HR+, HER2− Breast Cancer: A Narrative Review of the Clinical Evidence
-
HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies
